Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3512784, 12 pages
https://doi.org/10.1155/2017/3512784
Research Article

Effect of Gonadotropin Types and Indications on Homologous Intrauterine Insemination Success: A Study from 1251 Cycles and a Review of the Literature

1ART and Reproductive Biology, University Hospital and School of Medicine, Picardie University Jules Verne, CHU Sud, 80054 Amiens, France
2PERITOX-INERIS Laboratory, CURS, Picardie University Jules Verne, CHU Sud, 80054 Amiens, France
3Laboratoire Lavergne, ACCOLAB, 75016 Paris, France
4Unilabs France et ForteBio, 1 rue Mozart, 92200 Clichy La Garenne, France

Correspondence should be addressed to Moncef Benkhalifa; moc.liamg@87fecnomafilahkneb

Received 2 August 2017; Revised 14 November 2017; Accepted 21 November 2017; Published 13 December 2017

Academic Editor: Marco Scioscia

Copyright © 2017 Rosalie Cabry-Goubet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Boivin, L. Bunting, J. A. Collins, and K. G. Nygren, “International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care,” Human Reproduction, vol. 22, no. 6, pp. 1506–1512, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Bushnik, J. L. Cook, A. A. Yuzpe, S. Tough, and J. Collins, “Estimating the prevalence of infertility in Canada,” Human Reproduction, vol. 27, no. 3, pp. 738–746, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Thoma, A. C. McLain, J. F. Louis et al., “Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach,” Fertility and Sterility, vol. 99, no. 5, pp. 1324–1331.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Slama, O. K. H. Hansen, B. Ducot et al., “Estimation of the frequency of involuntary infertility on a nation-wide basis,” Human Reproduction, vol. 27, no. 5, pp. 1489–1498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. The ESHRE Capri Workshop Group, “Intrauterine insemination,” Human Reproduction Update, vol. 15, no. 3, pp. 265–277, 2009. View at Publisher · View at Google Scholar
  6. S. Oehninger, “Place of intracytoplasmic sperm injection in management of male infertility,” The Lancet, vol. 357, no. 9274, pp. 2068-2069, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Abdelkader and J. Yeh, “The potential use of intrauterine insemination as a basic option for infertility: a review for technology-limited medical settings,” Obstetrics and Gynecology International, vol. 2009, Article ID 584837, 11 pages, 2009. View at Publisher · View at Google Scholar
  8. T. Katzorke and F. B. Kolodziej, “Significance of insemination in the era of IVF and ICSI,” Der Urologe—Ausgabe A, vol. 49, no. 7, pp. 842–846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Monraisin, L. Chansel-Debordeaux, A. Chiron et al., “Evaluation of intrauterine insemination practices: a 1-year prospective study in seven French assisted reproduction technology centers,” Fertility and Sterility, vol. 105, no. 6, pp. 1589–1593, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Campana, D. Sakkas, A. Stalberg et al., “Intrauterine insemination: evaluation of the results according to the woman's age, sperm quality, total sperm count per insemination and life table analysis,” Human Reproduction, vol. 11, no. 4, pp. 732–736, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Khalil, P. E. Rasmussen, K. Erb, S. B. Laursen, S. Rex, and L. G. Westergaard, “Homologous intrauterine insemination. An evaluation of prognostic factors based on a review of 2473 cycles,” Acta Obstetricia et Gynecologica Scandinavica, vol. 80, no. 1, pp. 74–81, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Kamath, P. T. K. Bhave, T. K. Aleyamma et al., “Predictive factors for pregnancy after intrauterine insemination: a prospective study of factors affecting outcome,” Journal of Human Reproductive Sciences, vol. 3, no. 3, pp. 129–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. A. Tijani and S. Bhattacharya, “The role of intrauterine insemination in male infertility,” Human Fertility, vol. 13, no. 4, pp. 226–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Souter, L. M. Baltagi, D. Kuleta, J. D. Meeker, and J. C. Petrozza, “Women, weight, and fertility: the effect of body mass index on the outcome of superovulation/intrauterine insemination cycles,” Fertility and Sterility, vol. 95, no. 3, pp. 1042–1047, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Soria, G. Pradillo, J. García et al., “Pregnancy predictors after intrauterine insemination: analysis of 3012 cycles in 1201 couples,” Journal of Reproduction and Infertility, vol. 13, no. 3, pp. 158–166, 2012. View at Google Scholar · View at Scopus
  16. B. Dilbaz, E. Özkaya, and M. Çinar, “Predictors of total gonadotropin dose required for follicular growth in controlled ovarian stimulation with intrauterin insemination cycles in patients with unexplained infertility or male subfertility,” Gynecology, Obstetrics and Reproductive Medicine, vol. 17, no. 1, Article ID 20016, 2001. View at Google Scholar
  17. A. J. Goverde, J. McDonnell, J. P. W. Vermeiden, R. Schats, F. F. H. Rutten, and J. Schoemaker, “Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis,” The Lancet, vol. 355, no. 9197, pp. 13–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Kim, T. Child, and C. Farquhar, “Intrauterine insemination: A UK survey on the adherence to NICE clinical guidelines by fertility clinics,” BMJ Open, vol. 5, no. 5, Article ID e007588, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Prado-Perez, C. Navarro-Maritnez, E. Lopez-Rivadeneira, and E. Sanon-Julien Flores, “The impact of endometriosis on the rate of pregnancy of patients submitted to intrauterine insemination,” Fertility and Sterility, vol. 77, supplement 1, p. S51, 2002. View at Publisher · View at Google Scholar
  20. W. P. Dmowski, M. Pry, J. Ding, and N. Rana, “Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer,” Fertility and Sterility, vol. 78, no. 4, pp. 750–756, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Härkki, A. Tiitinen, and O. Ylikorkala, “Endometriosis and assisted reproduction techniques,” Annals of the New York Academy of Sciences, vol. 1205, pp. 207–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Matorras, V. Recio, B. Corcóstegui, and F. J. Rodríguez-Escudero, “Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husband's spermatozoa,” Human Reproduction, vol. 15, no. 6, pp. 1231–1234, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Gerli, V. Bini, and G. C. D. Renzo, “Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: a statistical model-derived analysis,” Gynecological Endocrinology, vol. 24, no. 1, pp. 18–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Ragni, F. Alagna, C. Brigante et al., “GnRH antagonists and mild ovarian stimulation for intrauterine insemination: A randomized study comparing different gonadotrophin dosages,” Human Reproduction, vol. 19, no. 1, pp. 54–58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Demirol and T. Gurgan, “Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study,” Human Reproduction, vol. 22, no. 1, pp. 97–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. World Health Organization, WHO Laboratory Manual for the Examination and Processing of Human Semen, World Health Organization, Geneva, Switzerland, 2010.
  27. W. Ombelet, P. Puttemans, and E. Bosmans, “Intrauterine insemination: a first-step procedure in the algorithm of male subfertility treatment,” Human Reproduction, vol. 10, supplement 1, pp. 90–102, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Ibérico, J. Vioque, N. Ariza et al., “Analysis of factors influencing pregnancy rates in homologous intrauterine insemination,” Fertility and Sterility, vol. 81, no. 5, pp. 1308–1313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Steures, J. W. van der Steeg, P. G. Hompes et al., “Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial,” The Lancet, vol. 368, no. 9531, pp. 216–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Merviel, M. H. Heraud, N. Grenier, E. Lourdel, P. Sanguinet, and H. Copin, “Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature,” Fertility and Sterility, vol. 93, no. 1, pp. 79–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Moro, E. Scarinci, C. Palla et al., “Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT,” Human Reproduction, vol. 30, no. 1, pp. 179–185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. R. P. Dickey, T. T. Olar, S. N. Taylor, D. N. Curole, and P. H. Rye, “Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone,” Human Reproduction, vol. 8, no. 1, pp. 56–59, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. P. D. Manganiello, J. E. Stern, T. A. Stukel, H. Crow, T. Brinck-Johnsen, and J. E. Weiss, “A comparison of clomiphene citrate and human menopausal gonadotropin for use in conjunction with intrauterine insemination,” Fertility and Sterility, vol. 68, no. 3, pp. 405–412, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. D. S. Guzick, M. W. Sullivan, G. D. Adamson et al., “Efficacy of treatment for unexplained infertility,” Fertility and Sterility, vol. 70, no. 2, pp. 207–213, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. E. G. Hughes, “timulated intra‐uterine insemination is not a natural choice for the treatment of unexplained subfertility: 'Effective treatment' or 'not a natural choice'?” Human Reproduction, vol. 18, no. 5, pp. 912–914, 2003. View at Publisher · View at Google Scholar
  36. M. Erdem, S. Abay, A. Erdem et al., “Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 189, pp. 33–37, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. M. Hassan and S. R. Killick, “Negative lifestyle is associated with a significant reduction in fecundity,” Fertility and Sterility, vol. 81, no. 2, pp. 384–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Dinelli, B. Courbière, V. Achard et al., “Prognosis factors of pregnancy after intrauterine insemination with the husband's sperm: conclusions of an analysis of 2,019 cycles,” Fertility and Sterility, vol. 101, no. 4, pp. 994–1000, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. B. J. Cohlen, P. Vandekerckhove, E. R. te Velde, and J. D. Habbema, “Timed intercourse versus intra‐uterine insemination with or without ovarian hyperstimulation for subfertility in men,” The Cochrane Library, 2007. View at Google Scholar
  40. H. Bry-Gauillard, S. Coulondre, I. Cédrin-Durnerin, and J. N. Hugues, “Advantages and risks of ovarian stimulation before intra-uterine inseminations,” Gynécologie Obstétrique & Fertilité, vol. 28, no. 11, pp. 820–831, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Casadei, V. Zamaro, M. Calcagni, C. Ticconi, M. Dorrucci, and E. Piccione, “Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 129, no. 2, pp. 155–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. E. Cantineau, B. J. Cohlen, and M. J. Heineman, “Ovarian stimulation protocols (anti‐oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility,” The Cochrane Library, 2007. View at Google Scholar · View at Scopus
  43. T. Dankert, J. A. M. Kremer, B. J. Cohlen et al., “A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility,” Human Reproduction, vol. 22, no. 3, pp. 792–797, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Gerli, M. L. Casini, V. Unfer, L. Costabile, V. Bini, and G. C. Di Renzo, “Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: A prospective, randomized analysis of cost effectiveness,” Fertility and Sterility, vol. 82, no. 3, pp. 573–578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Kocak, B. Dilbaz, B. Demir et al., “Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study,” Gynecological Endocrinology, vol. 26, no. 6, pp. 429–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Sagnella, F. Moro, A. Lanzone et al., “A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor,” Fertility and Sterility, vol. 95, no. 2, pp. 689–694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Matorras, C. Osuna, A. Exposito, L. Crisol, and J. I. Pijoan, “Recombinant FSH versus highly purified FSH in intrauterine insemination: systematic review and metaanalysis,” Fertility and Sterility, vol. 95, no. 6, pp. 1937–e3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Balasch, F. Fábregues, J. Peñarrubia et al., “Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients,” Journal of Assisted Reproduction and Genetics, vol. 15, no. 9, pp. 552–559, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Balasch, F. Miró, I. Burzaco et al., “Endocrinology: The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone,” Human Reproduction, vol. 10, no. 7, pp. 1678–1683, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. N. F. Vlahos, L. Coker, C. Lawler, Y. Zhao, B. Bankowski, and E. E. Wallach, “Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin,” Fertility and Sterility, vol. 83, no. 5, pp. 1510–1516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. A. De la Fuente, “Evaluation of the effectiveness, safety and cost-effectiveness of highly purified human menopausal gonadotropin. Study of use Menopur in Intrauterine Artificial Insemination (IAC/IAD),” Fertility Review, vol. 24, pp. 363–367, 2007. View at Google Scholar
  52. M. Filicori, G. E. Cognigni, P. Pocognoli et al., “Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone,” Fertility and Sterility, vol. 80, no. 2, pp. 390–397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Gomez, M. Schorsch, J. Steetskamp et al., “The effect of ovarian stimulation on the outcome of intrauterine insemination,” Archives of Gynecology and Obstetrics, vol. 289, no. 1, pp. 181–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Isaza, A. Requena, J. A. García-Velasco, J. Remohí, A. Pellicer, and C. Simón, “Recombinant versus urinary follicle-stimulating hormone in couples undergoing intrauterine insemination: a randomized study,” Obstetrics, Gynaecology and Reproductive Medicine, vol. 48, no. 2, pp. 112–118, 2003. View at Google Scholar · View at Scopus
  55. P. Gallot-Lavallée, R. Ecochard, C. Mathieu et al., “Clomiphene citrate or hMg: which ovarian stimulation to chose before intra-uterine inseminations? A meta-analysis,” Contraception, Fertilite, Sexualite, vol. 23, pp. 115–121, 1995. View at Google Scholar
  56. R. R. Dickey and R. Ramasamy, “Role of male factor testing in recurrent pregnancy loss or in vitro fertilization failure,” Reproductive System & Sexual Disorders, vol. 04, no. 03, 2015. View at Publisher · View at Google Scholar
  57. K. R. Hansen, A. L. W. He, A. K. Styer et al., “Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation–intrauterine insemination,” Fertility and Sterility, vol. 105, no. 6, pp. 1575–1583.e2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Erdem, A. Erdem, M. F. Mutlu et al., “The impact of sperm morphology on the outcome of intrauterine insemination cycles with gonadotropins in unexplained and male subfertility,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 197, pp. 120–124, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. NICE, Nice guideline: Fertility: for people with fertility problems. NICE clinical guideline 156 February, 1.8.1.3–4, 2013.
  60. S. Nuojua-Huttunen, C. Tomas, R. Bloigu, L. Tuomivaara, and H. Martikainen, “Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome,” Human Reproduction, vol. 14, no. 3, pp. 698–703, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. S. K. Toma, D. W. Stovall, and M. G. Hammond, “The effect of laparoscopic ablation or danocrine on pregnancy rates in patients with stage I or II endometriosis undergoing donor insemination,” Obstetrics & Gynecology, vol. 80, no. 2, pp. 253–256, 1992. View at Google Scholar · View at Scopus
  62. V. Blasco, N. Prados, F. Carranza, C. González-Ravina, A. Pellicer, and M. Fernández-Sánchez, “Influence of follicle rupture and uterine contractions on intrauterine insemination outcome: a new predictive model,” Fertility and Sterility, vol. 102, no. 4, pp. 1034–1040, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. B. J. Van Voorhis, M. Barnett, A. E. T. Sparks, C. H. Syrop, G. Rosenthal, and J. Dawson, “Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization,” Fertility and Sterility, vol. 75, no. 4, pp. 661–668, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Mathieu, R. Ecochard, V. Bied, J. Lornage, and J. C. Czyba, “Andrology: cumulative conception rate following intrauterine artificial insemination with husband's spermatozoa: influence of husband's age,” Human Reproduction, vol. 10, no. 5, pp. 1090–1097, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. P. R. Brzechffa, S. Daneshmand, and R. P. Buyalos, “Sequential clomiphene citrate and human menopausal gonadotrophin with intrauterine insemination: the effect of patient age on clinical outcome,” Human Reproduction, vol. 13, no. 8, pp. 2110–2114, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. P. Bakas, I. Boutas, M. Creatsa et al., “Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?” Gynecological Endocrinology, vol. 31, no. 10, pp. 765–768, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. B. N. Hendin, T. Falcone, J. Hallak et al., “The effect of patient and semen characteristics on live birth rates following intrauterine insemination: a retrospective study,” Journal of Assisted Reproduction and Genetics, vol. 17, no. 5, pp. 245–252, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Aydin, H. Hassa, T. Oge, and V. Y. Tokgoz, “Factors predictive of clinical pregnancy in the first intrauterine insemination cycle of 306 couples with favourable female patient characteristics,” Human Fertility, vol. 16, no. 4, pp. 286–290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. M. Plosker, W. Jacobson, and P. Amato, “Infertility: Predicting and optimizing success in an intra-uterine insemination programme,” Human Reproduction, vol. 9, no. 11, pp. 2014–2021, 1994. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Oehninger, D. Franken, and T. Kruger, “Approaching the next millennium: How should we manage andrology diagnosis in the intracytoplasmic sperm injection era?” Fertility and Sterility, vol. 67, no. 3, pp. 434–436, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. U. Dorjpurev, A. Kuwahara, Y. Yano et al., “Effect of semen characteristics on pregnancy rate following intrauterine insemination,” Journal of Medical Investigation, vol. 58, no. 1-2, pp. 127–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. H. E. Duran, M. Morshedi, T. Kruger, and S. Oehninger, “Intrauterine insemination: a systematic review on determinants of success,” Human Reproduction Update, vol. 8, no. 4, pp. 373–384, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Belaisch-Allart, J. M. Mayenga, and M. Plachot, “Intra-uterine insemination,” Contraception, fertilité, sexualité (1992), vol. 27, no. 9, pp. 614–619, 1999. View at Google Scholar · View at Scopus
  74. K. Sakhel, T. Abozaid, S. Schwark, M. Ashraf, and M. Abuzeid, “Semen parameters as determinants of success in 1662 cycles of intrauterine insemination after controlled ovarian hyperstimulation,” Fertility and Sterility, vol. 84, pp. S248–S249, 2005. View at Publisher · View at Google Scholar
  75. B. A. Stone, J. M. Vargyas, G. E. Ringlet et al., “Determinants of the outcome of intrauterine insemination: analysis of outcomes of 9963 consecutive cycles,” American Journal of Obstetrics & Gynecology, vol. 180, no. 6 I, pp. 1522–1534, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Strandell, C. Bergh, B. Söderlund, K. Lundin, and L. Nilsson, “Fallopian tube sperm perfusion: the impact of sperm count and morphology on pregnancy rates,” Acta Obstetricia et Gynecologica Scandinavica, vol. 82, no. 11, pp. 1023–1029, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. H.-Y. Huang, C.-L. Lee, Y.-M. Lai et al., “The impact of the total motile sperm count on the success of intrauterine insemination with husband's spermatozoa,” Journal of Assisted Reproduction and Genetics, vol. 13, no. 1, pp. 56–63, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. R. P. Dickey, R. Pyrzak, P. Y. Lu, S. N. Taylor, and P. H. Rye, “Comparison of the sperm quality necessary for successful intrauterine insemination with World Health Organization threshold values for normal sperm,” Fertility and Sterility, vol. 71, no. 4, pp. 684–689, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. D. C. Miller, B. K. Hollenbeck, G. D. Smith et al., “Processed total motile sperm count correlates with pregnancy outcome after intrauterine insemination,” Urology, vol. 60, no. 3, pp. 497–501, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Yousefi and A. Azargon, “Predictive factors of intrauterine insemination success of women with infertility over 10 years,” Journal of the Pakistan Medical Association, vol. 61, no. 2, pp. 165–168, 2011. View at Google Scholar · View at Scopus
  81. A. Yavuz, O. Demirci, H. Sözen, and M. Uludoǧan, “Predictive factors influencing pregnancy rates after intrauterine insemination,” Iranian Journal of Reproductive Medicine, vol. 11, no. 3, pp. 227–234, 2013. View at Google Scholar · View at Scopus
  82. Z. S. Ozkan, R. Ilhan, M. Ekinci, H. Timurkan, and E. Sapmaz, “Impact of estradiol monitoring on the prediction of intrauterine insemination outcome,” Journal of Taibah University Medical Sciences, vol. 9, no. 1, pp. 36–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. I. Kaarouch, N. Bouamoud, N. Louanjli et al., “Impact of sperm genome decay on Day-3 embryo chromosomal abnormalities from advanced-maternal-age patients,” Molecular Reproduction and Development, vol. 82, no. 10, pp. 809–819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. H. K. A. Snick, T. S. Snick, J. L. H. Evers, and J. A. Collins, “The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study,” Human Reproduction, vol. 12, no. 7, pp. 1582–1588, 1997. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Collins, “Current best evidence for the advanced treatment of unexplained subfertility,” Human Reproduction, vol. 18, no. 5, pp. 907–912, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. R. Cabry-Coubert, F. Scheffler, N. Belhadri-Mansouri et al., Effect of Gonadotropin types and indications on homologous intrauterine insemination success: A Study from 1251 Cycles and a review of the literature, Rbm Online, 2016.